Pfizer Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Sep ' 23	Sep ' 22	Mar ' 22	Sep ' 21	Sep ' 20

Sales

1,106.57

1,230.37

1,225.56

1,385.43

1,110.30

Operating profit

293.32

423.54

360.62

475.11

389.61

Interest

5.60

7.02

6.03

4.46

7.72

Gross profit

357.25

458.78

389.97

497.92

411.24

EPS (Rs)

53.00

75.11

58.95

74.94

55.92

Other income

69.53

42.26

35.38

27.27

29.35

Stock adjustment

24.75

14.70

-18.49

-54.41

10.99

Raw material

169.89

184.67

163.34

190.95

156.33

Power and fuel

-

-

-

-

-

Employee expenses

183.32

174.68

202.04

201.63

172.11

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

435.29

432.78

518.05

572.15

381.26

Provisions made

-

-

-

-

-

Depreciation

30.98

52.76

60.77

54.23

54.87

Taxation

83.78

114.99

59.50

100.83

100.55

Net profit / loss

242.49

343.62

269.70

342.86

255.82

Extra ordinary item

-

52.59

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

45.75

45.75

45.75

45.75

45.75

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

26.51

34.42

29.42

34.29

35.09

GPM (%)

30.38

36.05

30.93

35.25

36.08

NPM (%)

20.62

27.00

21.39

24.27

22.45